The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function

Published:2021-09 Issue:19 Volume:184 Page:4981-4995.e14
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Johnson Lexus R.,Lee Daniel Y.,Eacret Jacqueline S.,Ye Darwin,June Carl H.,Minn Andy J.

Funder

Merck

Parker Institute for Cancer Immunotherapy

The Mark Foundation for Cancer Research

NIH

Breast Cancer Research Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference58 articles.

1. Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics;Alshetaiwi;Sci. Immunol.,2020

2. Chromosomal instability drives metastasis through a cytosolic DNA response;Bakhoum;Nature,2018

3. Developmental Relationships of Four Exhausted CD8 (T Cell Subsets Reveals Underlying Transcriptional and Epigenetic Landscape Control Mechanisms;Beltra;Immunity,2020

4. Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade;Benci;Cell,2016

5. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade;Benci;Cell,2019

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Jump-starting chimeric antigen receptor-T cells to go the extra mile with nanotechnology;Current Opinion in Biotechnology;2024-10

2. Chimeric antigen receptor (CAR) T-cell therapy: Harnessing extracellular vesicles for enhanced efficacy;Pharmacological Research;2024-10

3. Exosome-based nanoparticles and cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-10

4. Dual Oxygen‐Supply Immunosuppression‐Inhibiting Nanomedicine to Avoid the Intratumoral Recruitment of Myeloid‐Derived Suppressor Cells;Small;2024-09-05

5. Exosomes of immune cell origin and their therapeutic potential for tumors;VIEW;2024-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3